Major Singaporean companies producing pharmaceuticals

Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that iX Biopharma Ltd. is currently the highest-volume asset, while China Medical System Holdings Ltd. tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol
Mkt cap
Price
Chg %
Vol
Rel vol
P/E
EPS dil
TTM
EPS dil growth
TTM YoY
Div yield %
TTM
Sector
Analyst rating
T14Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class S
5.3 B SGD2.59 USD−1.52%110 K0.8615.220.22 SGD−73.53%26.45%Health technology
Buy
8A8China Medical System Holdings Ltd.
4.03 B SGD1.71 SGD+6.87%1 K0.6214.550.12 SGD−1.06%3.39%Health technology
Strong buy
H02Haw Par Corporation Limited
2.83 B SGD12.60 SGD−2.55%320.15 K1.9212.171.04 SGD−8.48%3.13%Health technology
Neutral
42CiX Biopharma Ltd.
531.56 M SGD0.450 SGD−4.26%7.07 M0.94———0.00%Health technology
Strong buy
1J5Hyphens Pharma International Ltd.
111.31 M SGD0.350 SGD−2.78%40.8 K0.8712.820.03 SGD+31.25%4.17%Health technology
Strong buy
BFKPharmesis International Ltd.
3.17 M SGD0.090 SGD−10.00%9000.45—−0.04 SGD−169.80%0.00%Health technology
No rating